Editorial: Prions and precautions: Be careful for what you ask

Transfusion

Volumn 50, Issue 5, 2010, Pages 956-958

  Dodd, Roger Y ^a  

^a HOLLAND LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

BLOOD COMPONENT; BLOOD DONOR; BLOOD SAMPLING; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CREUTZFELDT JAKOB DISEASE; EDITORIAL; ERYTHROCYTE; GENE AMPLIFICATION; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; PATIENT SAFETY; PRION; PRION DISEASE; PROTEIN MISFOLDING CYCLIC AMPLIFICATION; QUALITY CONTROL; WESTERN BLOTTING; DISEASE TRANSMISSION; HUMAN; PROTEIN FOLDING;

BLOOD DONORS; BLOOD TRANSFUSION; HUMANS; PRION DISEASES; PROTEIN FOLDING;

EID: 77951698294     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02638.x     Document Type: Editorial

References (9)

1. Foster KR, Vecchia P, Repacholi MH. Risk management. Science and the precautionary principle. Science 2000 288 : 979 81.
2. Wilson K, Ricketts MN. The success of precaution? Managing the risk of transfusion transmission of variant Creutzfeldt-Jakob disease. Transfusion 2004 47 : 1475 8. (Pubitemid 39318983)
3. Sowemimo-Coker SO, Demczyk CA, Andrade F, Baker CA. Evaluation of the efficacy of prion-reduction filters for red cell concentrates with a new rapid and highly sensitive cell-culture based infectivity assay. Transfusion 2010 50 : 980 8.
4. Wiltshire M, Thomas S, Scott J, Hicks V, Haines M, Cookson P, Garwood M, Cardigan R. Prion reduction of red cells: Impact on component quality. Transfusion 2010 50 : 970 9.
5. Saborio GP, Permanne B, Soto C. Sensitive detection of prion protein by cyclic amplification of protein misfolding. Nature 2001 411 : 810 3. (Pubitemid 32588105)
6. Tattum MH, Jones S, Pal S, Collinge J, Jackson GS. Discrimination between prion-infected and normal blood samples by protein misfolding cyclic amplification at a pre-clinical stage. Transfusion 2010 50 : 996 1002.
7. Deleault NR, Harris BT, Rees JR, Supattone S. Formation of native prions from minimal components in vitro. PNAS 2007 104 : 9741 6.
8. TSE in plasma: initial results with 20,000 samples. Transfusion 2010 50 : 989 95.
9. Chohan G, Llewelyn C, Mackenzie J, Cousens S, Kennedy A, Will R, Hewitt P. Variant Creutzfeldt-Jakob disease in a transfusion recipient: coincidence or cause? Transfusion 2010 50 : 1003 6.